Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues, net	$ 37,093	$ 41,189
Cost of revenues	24,278	26,041
Gross profit	12,815	15,148
Operating expense:
General and administrative	15,249	14,731
Research and development	1,171	597
Total operating expense	16,420	15,328
Loss from operations	(3,605)	(180)
Other (expense) income:
Interest expense, net	(2,607)	(2,447)
Other expense, net	(199)	(22)
Change in fair value of derivative liabilities	192	(224)
Total other expense	(2,614)	(2,693)
Loss before income taxes	(6,219)	(2,873)
Income tax expense	(870)	(51)
Net loss	(7,089)	(2,924)
Fixed dividends - Series B Preferred	(317)	(317)
Net loss attributable to common stockholders - basic	(7,406)	(3,241)
Net loss attributable to common stockholders - diluted	(7,406)	(3,241)
Comprehensive loss:
Net loss	(7,089)	(2,924)
Other comprehensive loss:
Foreign currency translation adjustment	(811)	558
Total comprehensive loss	$ (7,900)	$ (2,366)
Net loss per common share – basic, as adjusted (in dollars per share)	$ (0.76)	$ (0.35)
Net loss per common share - diluted, as adjusted (in dollars per share)	$ (0.76)	$ (0.35)
Weighted average number of common shares outstanding – basic, as adjusted (in shares)	9,714	9,366
Weighted average number of common shares outstanding – diluted, as adjusted (in shares)	9,714	9,366